Jessica M. Stempel
@JMStempel
Followers
234
Following
834
Media
2
Statuses
163
Faculty @OHSUKnight l @YaleHemOnc Fellow l @ASH_hematology Trainee Council 2022-2024 l MD-UCV 🇻🇪 - views are my own
Portland, OR
Joined May 2021
2
5
48
Dr. Nikolai Podoltsev presents @eaonc E1910 Ph III trial of the addition of Blinatumomab to consolidation therapy for older, newly diagnosed patients with BCR::ABL1 negative B-Lineage Acute Lymphoblastic Leukemia #ALL #ASH24 with Selina Loger, MD @PennCancer & @MRLitzow
1
4
17
Celebrating Dr. Jennifer Afranie-Sakyi, @YaleHemOnc, and her presentation of implementation rates of the @ASH_hematology cerebrovascular guideline screening for silent cerebral infarct and cognition in #sicklecelldisease #SCD at #ASH24! @cececalhounMD @YaleHematology
3
5
29
So proud of you Nicole!
Honored to have been invited back to @SHAhamden to talk to this brilliant group of SHA girls about my journey through medical training. Thanks for having me! 🩺🗒️
0
1
12
Had an amazing time at #ASH2024 meeting friends, attending great talks and finally getting the great news of passing my Hematology ABIM while enjoying this great view of SD.
3
5
46
Dr Luca Lanino @YaleCancer @HumanitasMilano presenting an excellent project that developed a molecular classification & a new, independently validated, risk stratification tool that outperformed all the other available for #CMML in collaboration with @genomed4all @ic_MDS
0
4
15
.@KunalPotnis reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 @GeorgeGoshuaMD @YaleHematology @SmilowCancer
https://t.co/ztySpPoq7K
3
9
53
Excited to share our work! Thank you @Dr_AmerZeidan @Dr_RoryShallis for your mentorship and support!
Dr @JMStempel fantastically presented our investigator-initiated randomized phase 2 trial of aza-ven +/- Pembro in older #AMLsm #ASH24 which was unfortunately -ve but showed importance of using ELN2024 for risk stratification & feasibility of central MRD in primary endpoint #IMG
1
4
19
An overview of treatment patterns & outcomes of CAR-T & Bispecific T-Cell Engager BiTE therapies in Relapsed/Refractory #MultipleMyeloma from @SmilowCancer @YaleCancer, presented by Poy Theprungsirikul, MD @YaleHemOnc #ASH24 @NataliaNeparid1 @YaleHematology
1
4
23
Incredible work by @Alhajahjeh_Abd !!
Thank you @Dr_AmerZeidan for all the great support you give me I will make sure to be at the intended level.
1
0
2
Happy to present on behalf of my coauthors including you!
Congratulations to Dr Parker on her outstanding data from amyloidosis trial!!!
1
3
18
2
4
25
.@JMStempel & Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor + Eltrombopag is effective in reducing transfusion requirements for patients w acquired #AplasticAnemia. #ASH24 @SmilowCancer @YaleHemOnc @YaleHematology @OncoAlert
1
8
29
It was a pleasure to participate in this rapid mentoring sessions! Always happy to contribute even with encouraging words in the journey of the next generation of hematologists ❤️ @KellyMezaMD @MaryCushmanMD
@GomezDLeonMD @JMStempel
#mentoring #ASHEducation #ASH24
0
2
22
@Dr_AmerZeidan @YaleMed @Alhajahjeh_Abd Wondering why so many clinical trials end prematurely? Our latest research digs into this critical issue. This work would not have been possible without such an excellent team @Alhajahjeh_Abd @JMStempel @Dr_AmerZeidan @MaxStahlMD @BewersdorfJan...@TradIMYale @YaleMedPSTP
0
5
9
🚨Calling all Hematology & Oncology doctors! Please take this 5-minute survey on grit and resilience ➡ https://t.co/8HIj6iTX4z
0
8
13
It might take us a second to coordinate getting a group picture, but it's because we just like each other. And we certainly love our first year fellows class! It was a joy learning about each of you at the Heme-Onc Fellows Welcome Party. You already make our family richer. 💙
0
6
35
Grateful for the opportunity to join this phenomenal group of current & future leaders of #cancer research at the @ASCO @AACR #MCCR #VailWorkshop. Huge thanks🙏🏼to all the organizers & faculty esp patient advocates. Shoutout to the best PDG-12!! #mssm @Myeloma_Society @theMMRF
1
5
44
Check out our research paper on the clinical and molecular features of extramedullary AML @LeukemiaJnl. Grateful for the amazing co-authors @ClevelandClinic. @CarmeloGurnari @Bahaj_MD @olisaogbue
@CarrawayHetty @VisconteValeria
https://t.co/jHSDfw1dLR
nature.com
Leukemia - Clinical and molecular characteristics of extramedullary acute myeloid leukemias
3
14
46